Breaking News Instant updates and real-time market news.

NDAQ

Nasdaq

$65.94

-0.48 (-0.72%)

, SHPG

Shire

$190.31

-7.39 (-3.74%)

20:02
10/11/16
10/11
20:02
10/11/16
20:02

Shire to replace Linear Technology on NASDAQ-100 Index, Equal Weighted Index

Nasdaq (NDAQ) announced that Shire (SHPG) will become a component of the NASDAQ-100 Index (NDX) and the NASDAQ-100 Equal Weighted Index prior to market open on Wednesday, October 19, 2016. Shire plc will replace Linear Technology Corporation (LLTC) in the indexes.

NDAQ

Nasdaq

$65.94

-0.48 (-0.72%)

SHPG

Shire

$190.31

-7.39 (-3.74%)

NDX

Nasdaq 100 Index

$4,821.91

-71.8539 (-1.47%)

LLTC

Linear Technology

$59.11

-0.39 (-0.66%)

  • 23

    Oct

  • 26

    Oct

NDAQ Nasdaq
$65.94

-0.48 (-0.72%)

07/05/16
EVER
07/05/16
DOWNGRADE
EVER
Hold
Nasdaq downgraded to Hold from Buy at Evercore ISI
Evercore ISI analyst Warren Gardiner downgraded Nasdaq to Hold and lowered its price target to $68 from $69. The analyst downgraded shares citing relative valuation and market share pressure in both US options and US cash equities. Gardiner said BATS/MIAX are approaching launch dates for their complex option venues, which will likely take share.
05/20/16
05/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on the today's top analyst initiations with this list compiled by The Fly: 1. IntercontinentalExchange (ICE) initiated with a Buy at Sterne Agee CRT by analyst Jason Weaver, who put a $300 price target on shares. The firm has a positive view of what it sees as the company's "leading position and growth trajectory in energy, equity, and fixed income trading and clearing." The firm adds that the company's revenue mix is less volatile than its peers, while synergies and cost controls have made the company more profitable. Weaver also initiated Nasdaq (NDAQ) with a Buy rating and $76 price target, CME Group (CME) with a Neutral rating and $90 price target and CBOE Holdings (CBOE) with an Underperform rating and $56 price target. 2. Akari Therapeutics (AKTX) initiated with a Buy rat Canaccord. The firm set a $33 price target on shares and cited expectations for FDA product approvals and a level of underappreciation by investors for its shares. 3. Ralph Lauren (RL) initiated with a Buy and $115 price target by BB&T analyst Corinna Freedman, who believes Ralph Lauren will be successful in its turnaround and gain relevancy among a new younger demographic due to its strong vertical global brand house with a powerful heritage and sees significant category opportunities remaining in Women's and Accessories. Additionally, Freedman said International growth opportunities remain and Club Monaco repositioning is underappreciated. 4. Johnson & Johnson (JNJ) initiated with a Sell at Standpoint Research and $94 target. 5. PACCAR (PCAR) initiated with a Hold at Argus. The firm said it expects challenging industry conditions to pressure earnings through 2017. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here
05/20/16
05/20/16
NO CHANGE

Nasdaq initiated at Sterne Agee CRT
As noted earlier, Sterne Agee CRT initiated Nasdaq with a Buy rating and $76 price target. The firm says that the company has diverse revenue streams that have growth potential, while it has "growing potential" in equities and equity derivatives.
05/19/16
05/19/16
INITIATION
Target $76

Buy
Nasdaq initiated with a Buy at Sterne Agee CRT
Sterne Agee CRT analyst Jason Weaver initiated Nasdaq with a Buy rating and $76 price target on shares.
SHPG Shire
$190.31

-7.39 (-3.74%)

09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.
09/26/16
HSBC
09/26/16
DOWNGRADE
HSBC
Hold
Shire downgraded to Hold from Buy at HSBC
HSBC analyst Steve McGarry downgraded SHire to Hold saying valuation is no longer compelling.
08/31/16
JEFF
08/31/16
NO CHANGE
Target $262
JEFF
Buy
Shire making right moves in dry eye market, says Jefferies
After hosting meetings with management, Jefferies analyst David Steinberg believes Shire (SHPG) is making "all the right moves" to make its dry eye drug Xiidra a potential $2B peak product in the U.S. Shire's Xiidra is competing with Allergan's (AGN) $1.4B dry eye drug Restasis, Steinberg tells investors in a research note. The analyst does not think Shire will have any problem exceeding the drug's consensus sales forecast of $200M for next year. He keeps a Buy rating on the shares with a $262 price target.
08/03/16
LEER
08/03/16
NO CHANGE
Target $231
LEER
Outperform
Shire price target raised to $231 from $213 at Leerink
Leerink analyst Jason Gerberry raised his price target for Shire to $231 from $213 on valuation after the company reported "solid" Q2 results. The analyst reiterates an Outperform rating on the shares.
NDX Nasdaq 100 Index
$4,821.91

-71.8539 (-1.47%)

LLTC Linear Technology
$59.11

-0.39 (-0.66%)

07/27/16
07/27/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Twitter (TWTR) downgraded to Hold from Buy at Canaccord, to Hold from Buy at Axiom, and to Hold from Buy at Cantor. 2. Southwest (LUV) downgraded to Neutral from Overweight at JPMorgan with analyst Jamie Baker saying the company continues to resist industry efforts aimed at improving revenue, like bag fees and fare increases. 3. Globus Medical (GMED) downgraded to Market Perform from Outperform at Wells Fargo, to Market Perform from Outperform at Leerink, and to Hold from Buy at Canaccord. 4. Linear Technology (LLTC) downgraded to Equal Weight from Overweight at Morgan Stanley. 5. Analog Devices (ADI) downgraded to Neutral from Buy at Citi with analyst Christopher Danely saying he views the stock as fairly valued at current levels. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/28/16
UBSW
07/28/16
UPGRADE
Target $62
UBSW
Neutral
Linear Technology upgraded to Neutral from Sell at UBS
UBS upgraded Linear Technology (LLTC) to Neutral from Sell and raised it price target to $62 from $42 on shares after Analog Devices (ADI) agreed to acquire the company for $46 per share in cash and 0.2321 of a share of Analog Devices common stock per share.
08/18/16
RHCO
08/18/16
NO CHANGE
RHCO
Analog Devices guidance conservative, says SunTrust
SunTrust analyst William Stein says that Analog Devices (ADI) reported "great results," and provided "conservative" Q3 guidance. He expects the company to raise its guidance next quarter, and predicts that its Q3 EPS will beat expectations in the wake of its acquisition of Linerar Technology (LLTC). Stein keeps an $80 price target and Buy rating on Analog Devices.
09/06/16
SBSH
09/06/16
NO CHANGE
SBSH
Citi thinks Texas Instruments was other bidder for Linear
Citi analyst Christopher Danely points out that Analog Devices (ADI), in its S-4 registration for the Linear Technology (LLTC) acquisition, revealed a competitive bid for Linear from another party. The analyst believes Texas Instruments (TXN) was the other party since it is the only other analog company with enough size to do an acquisition of Linear's size.

TODAY'S FREE FLY STORIES

HGG

hhgregg

$0.45

0.0142 (3.26%)

15:39
02/23/17
02/23
15:39
02/23/17
15:39
Periodicals
hhgregg said to prepare bankruptcy filing as early as March, Bloomberg says »

Bloomberg added that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$72.14

0.43 (0.60%)

, TGT

Target

$65.62

-0.32 (-0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Periodicals
Trump supportive of border tax in Reuters interview »

Headlines crossing…

WMT

Wal-Mart

$72.14

0.43 (0.60%)

TGT

Target

$65.62

-0.32 (-0.49%)

HD

Home Depot

$145.17

-0.081 (-0.06%)

LOW

Lowe's

$76.40

-0.4 (-0.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 01

    Mar

  • 05

    Mar

  • 06

    Mar

  • 14

    Mar

  • 15

    Mar

  • 19

    Mar

OLED

Universal Display

$71.25

-0.3 (-0.42%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Options
Universal Display options imply 12.2% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story  »

Harmony Merger trading…

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:35
02/23/17
02/23
15:35
02/23/17
15:35
Hot Stocks
Breaking Hot Stocks news story on Harmony Merger Corp. »

Harmony Merger Corp.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORI

Old Republic

$20.95

-0.07 (-0.33%)

15:27
02/23/17
02/23
15:27
02/23/17
15:27
Hot Stocks
Old Republic raises dividend, extends shareholder rights plan, expands board »

Old Republic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPWR

SunPower

$8.46

-0.12 (-1.40%)

15:26
02/23/17
02/23
15:26
02/23/17
15:26
Options
SunPower call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXMD

TherapeuticsMD

$5.73

0.06 (1.06%)

15:24
02/23/17
02/23
15:24
02/23/17
15:24
Recommendations
TherapeuticsMD analyst commentary  »

TherapeuticsMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 01

    Mar

  • 21

    Mar

  • 07

    May

USB

U.S. Bancorp

$55.38

0.07 (0.13%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Periodicals
Trump considers outgoing U.S. Bancorp CEO for Fed board seat, Bloomberg says »

President Trump is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Mar

  • 15

    Mar

CENX

Century Aluminum

$14.48

-0.77 (-5.05%)

15:20
02/23/17
02/23
15:20
02/23/17
15:20
Options
Century Aluminum options imply 12.4% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

ICPT

Intercept

$122.79

-2.66 (-2.12%)

15:19
02/23/17
02/23
15:19
02/23/17
15:19
Recommendations
Intercept analyst commentary  »

Intercept shares defended…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 06

    Mar

$NSD

NASDAQ Market Internals

15:18
02/23/17
02/23
15:18
02/23/17
15:18
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:17
02/23/17
02/23
15:17
02/23/17
15:17
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VASC

Vascular Solutions

, TFX

Teleflex

$183.34

-0.67 (-0.36%)

15:16
02/23/17
02/23
15:16
02/23/17
15:16
Hot Stocks
Gabelli liquidates stake in Vascular Solutions »

As a result of the…

VASC

Vascular Solutions

TFX

Teleflex

$183.34

-0.67 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

UPS

UPS

$105.01

-0.615 (-0.58%)

15:12
02/23/17
02/23
15:12
02/23/17
15:12
Hot Stocks
Teamsters says UPS mechanics seek mediation release »

The Teamsters union…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

KMI

Kinder Morgan

15:11
02/23/17
02/23
15:11
02/23/17
15:11
Options
Notable call buying in Kinder Morgan »

Notable call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDT

Medtronic

$80.74

1.12 (1.41%)

15:06
02/23/17
02/23
15:06
02/23/17
15:06
Hot Stocks
Medtronic reports presentation of data on Solitaire stent retriever »

Medtronic said data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

ACIA

Acacia Communications

$62.22

-4.32 (-6.49%)

15:05
02/23/17
02/23
15:05
02/23/17
15:05
Options
Acacia Communications options imply 14.2% move in share price post-earnings, below median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 04

    Apr

  • 05

    Apr

HRMN

Harmony Merger Corp.

$10.24

0.0499 (0.49%)

15:04
02/23/17
02/23
15:04
02/23/17
15:04
Hot Stocks
Harmony Merger receives termination of merger pact from MUNDOmedia »

Harmony Merger announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$50.26

-0.08 (-0.16%)

15:02
02/23/17
02/23
15:02
02/23/17
15:02
Hot Stocks
Prologis raises annualized dividend level by 5% to $1.76 per share »

The Board of Directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

FDX

FedEx

$191.42

-2.4099 (-1.24%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Hot Stocks
FedEx extends relationship with Joe Gibbs Racing »

FedEx announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 06

    Mar

KATE

Kate Spade

$23.60

-0.24 (-1.01%)

15:01
02/23/17
02/23
15:01
02/23/17
15:01
Options
In the money call buying in Kate Spade »

In the money call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TANH

Tantech Holdings

$1.80

-0.04 (-2.17%)

15:00
02/23/17
02/23
15:00
02/23/17
15:00
Hot Stocks
Tantech Holdings CEO sees operating profits growing 'substantially faster' »

Tantech Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

15:00
02/23/17
02/23
15:00
02/23/17
15:00
General news
Treasury Closing Summary: »

Treasury Closing Summary:…

CME

CME Group

$122.51

1.46 (1.21%)

14:59
02/23/17
02/23
14:59
02/23/17
14:59
Hot Stocks
CME Group reports new record for Fed Fund futures contracts »

CME Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.